Drugs Made In America Acquisition Corp. DMAA
$10.80
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 86.78% | 583.02% | -- | -- | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.77% | -394.18% | -- | -- | -- |
| Change in Net Operating Assets | -78.14% | 59.62% | -- | -- | -- |
| Cash from Operations | -7.50% | -1.31% | -- | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 142.70% | 100.00% | -- | -- | -- |
| Cash from Investing | 142.70% | 100.00% | -- | -- | -- |
| Total Debt Issued | -74.78% | -92.79% | -- | -- | -- |
| Total Debt Repaid | -5,048.59% | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -99.92% | -99.87% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 333.28% | 100.00% | -- | -- | -- |
| Cash from Financing | -142.38% | -99.83% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6,600.00% | 7,100.00% | -- | -- | -- |